<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore is an inducer of cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>During the reperfusion phase after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, calcium accumulates in mitochondria, and a burst of free radical formation occurs, conditions that favor the activation of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore </plain></SENT>
<SENT sid="2" pm="."><plain>Here the authors demonstrate that a blocker of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore, the nonimmunosuppressive <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> analogue N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-Val-4-<z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (10 mg/kg intraperitoneally), administered during reperfusion and at 24 hours of reperfusion, diminishes <z:mpath ids='MPATH_124'>infarct</z:mpath> size in a rat model of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> of 2 hours' duration </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore may be an important target for drugs against <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>